Michael Pratt

637 total citations
29 papers, 459 citations indexed

About

Michael Pratt is a scholar working on Surgery, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Michael Pratt has authored 29 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Otorhinolaryngology. Recurrent topics in Michael Pratt's work include Reconstructive Surgery and Microvascular Techniques (6 papers), Infectious Aortic and Vascular Conditions (4 papers) and Sinusitis and nasal conditions (4 papers). Michael Pratt is often cited by papers focused on Reconstructive Surgery and Microvascular Techniques (6 papers), Infectious Aortic and Vascular Conditions (4 papers) and Sinusitis and nasal conditions (4 papers). Michael Pratt collaborates with scholars based in United States, Poland and Puerto Rico. Michael Pratt's co-authors include Ya’an Kang, Jason B. Fleming, David Roife, Bingbing Dai, John R. Burnett, Xinqun Li, Paul D. Garen, Xiqi Li, Eugene J. Koay and James Schneider and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Michael Pratt

29 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pratt United States 13 125 120 116 57 52 29 459
Takashi Hiyama Japan 13 96 0.8× 76 0.6× 152 1.3× 24 0.4× 19 0.4× 58 484
Xiaojing Yang China 14 78 0.6× 167 1.4× 209 1.8× 92 1.6× 33 0.6× 55 594
Wilfredo Alejandro González‐Arriagada Chile 13 59 0.5× 124 1.0× 153 1.3× 64 1.1× 23 0.4× 56 476
R Allibone United Kingdom 12 157 1.3× 110 0.9× 167 1.4× 42 0.7× 20 0.4× 16 563
Michaela Andratschke Germany 15 106 0.8× 166 1.4× 146 1.3× 77 1.4× 37 0.7× 35 473
Jianfeng Wu China 12 100 0.8× 75 0.6× 214 1.8× 126 2.2× 19 0.4× 43 520
Yasuto Yoshihama Japan 15 117 0.9× 208 1.7× 244 2.1× 60 1.1× 36 0.7× 35 578
Kai Eichhorn Germany 7 44 0.4× 73 0.6× 121 1.0× 78 1.4× 14 0.3× 13 447
C Kittas Greece 15 86 0.7× 216 1.8× 197 1.7× 61 1.1× 19 0.4× 37 523
Koji Kawaguchi Japan 14 114 0.9× 164 1.4× 108 0.9× 23 0.4× 9 0.2× 54 476

Countries citing papers authored by Michael Pratt

Since Specialization
Citations

This map shows the geographic impact of Michael Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pratt more than expected).

Fields of papers citing papers by Michael Pratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pratt. The network helps show where Michael Pratt may publish in the future.

Co-authorship network of co-authors of Michael Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pratt. A scholar is included among the top collaborators of Michael Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pratt. Michael Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Chintan, Helena D. Zomer, Hari Prasad Osuru, et al.. (2021). Loss of TDP-43 in male germ cells causes meiotic failure and impairs fertility in mice. Journal of Biological Chemistry. 297(5). 101231–101231. 12 indexed citations
2.
Dutta, Prasanta, Jae-Hyuk Lee, Ya’an Kang, et al.. (2019). Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. Journal of Proteome Research. 18(7). 2826–2834. 25 indexed citations
3.
Roife, David, Bingbing Dai, Michael Pratt, et al.. (2019). Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. Surgery Open Science. 1(2). 56–63. 24 indexed citations
4.
Dai, Bingbing, David Roife, Ya’an Kang, et al.. (2017). Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(4). 662–670. 17 indexed citations
5.
Kang, Ya’an, David Roife, Michael Pratt, et al.. (2017). Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Oncogene. 36(38). 5432–5438. 35 indexed citations
6.
Kang, Ya’an, David Roife, Yeon‐Ju Lee, et al.. (2016). Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clinical Cancer Research. 22(19). 4934–4946. 29 indexed citations
7.
Roife, David, Bingbing Dai, Ya’an Kang, et al.. (2016). Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 22(24). 6021–6030. 46 indexed citations
8.
Roife, David, Bing Dai, Ya’an Kang, et al.. (2016). Auranofin to prevent progression of pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 34(4_suppl). 236–236. 7 indexed citations
9.
Li, Xiqi, David Roife, Ya’an Kang, et al.. (2016). Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition. Oncogene. 35(37). 4881–4890. 47 indexed citations
10.
Pratt, Michael, et al.. (1997). Combined endoscopic transnasal and transantral orbital decompression. American Journal of Otolaryngology. 18(3). 159–164. 4 indexed citations
11.
Pratt, Michael, et al.. (1995). Correlation between preoperative computed tomography and operative findings in functional endoscopic sinus surgery. The Laryngoscope. 105(9). 924–927. 24 indexed citations
12.
Williams, Patricia B., et al.. (1994). Long-term Pretreatment With Pentoxifylline Increases Random Skin Flap Survival. Archives of Otolaryngology - Head and Neck Surgery. 120(1). 65–71. 10 indexed citations
13.
Williams, Patricia B., et al.. (1994). Pharmacologic Enhancement of Random Skin Flap Survival by Prostaglandin E2. Archives of Otolaryngology - Head and Neck Surgery. 120(1). 56–60. 5 indexed citations
14.
Bank, Harvey L., Marcia K. Schmehl, Robert M. Warner, et al.. (1991). Transplantation of cryopreserved canine venous allografts. Journal of Surgical Research. 50(1). 57–64. 10 indexed citations
15.
Hinds, Pamela S., et al.. (1991). An Investigation of the Safety of the Blood Reinfusion Step Used With Tunneled Venous Access Devices in Children With Cancer. Journal of Pediatric Oncology Nursing. 8(4). 159–164. 6 indexed citations
16.
Pratt, Michael, et al.. (1990). Intramuscular hemangioma of the infratemporal fossa. Otolaryngology. 103(4). 637–641. 21 indexed citations
17.
Pratt, Michael, et al.. (1989). The use of pentoxifylline in a pig random skin flap model. The Laryngoscope. 99(6). 582–585. 11 indexed citations
18.
Pratt, Michael & John R. Burnett. (1988). Fulminant drechslera sinusitis in an immunocompetent host. The Laryngoscope. 98(12). 1343–1347. 29 indexed citations
19.
Pratt, Michael & Gary R. Warnock. (1987). Odontogenic Myxoma of the Maxilla. Otolaryngology. 96(3). 292–296. 11 indexed citations
20.
Pratt, Michael, et al.. (1986). Oculopharyngeal muscular dystrophy: Recent ultrastructural evidence for mitochondrial abnormalities. The Laryngoscope. 96(4). 368–373. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026